Remifentanil
| Remifentanil | |
|---|---|
| Salts [] | |
|---|---|
| Remifentanil hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 376.40 g/mol [1] |
| Appearance | Oil [1] |
| Melting point | Crystals from methanol + ether. MP: 212-214 °C /Remifentanil hydrochloride/ [1] |
| Solubility | Soluble in methanol, ethyl acetate [1] |
| Predicted LogP | 1.9 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C20H28N2O5 |
| IUPAC name | methyl 1-(3-methoxy-3-oxopropyl)-4-(N-propanoylanilino)piperidine-4-carboxylate |
| SMILES | CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC |
| InChI | InChI=1S/C20H28N2O5/c1-4-17(23)22(16-8-6-5-7-9-16)20(19(25)27-3)11-14-21(15-12-20)13-10-18(24)26-2/h5-9H,4,10-15H2,1-3H3 |
| InChIKey | ZTVQQQVZCWLTDF-UHFFFAOYSA-N |
| CAS number | 132875-61-7 |
| UNII | P10582JYYK |
| PubChem CID | 60815 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 1-20 minutes |
| Metabolism | cleaved by non-specific plasma and tissue esterases |
| Routes of administration | Intravenous |
Remifentanil (also known as Remifentanyl, ramifentanyl, Gi 87084x, Ultiva-, Remifentanilo, Ids-nr-005, 4-carboxy-4-(n-phenylpropionamido)-1-piperidinepropionic acid dimethyl ester, methyl 1-(3-methoxy-3-oxopropyl)-4-(N-phenylpropanamido)piperidine-4-carboxylate, remifentanilum or N01ah06) is a opioid substance of the aniline and amino acid class.
Chemistry
Salts []
Remifentanil is typically found in the form of its hydrochloride salt.
Stereochemistry []
Remifentanil is achiral.
Druglikeness
Lipinski's rule of five
Remifentanil matches Lipinski's rule of five.Pharmacology
ATC Classification
- nervous system (N)
- anesthetics (N01)
- anesthetics, general (N01A)
- opioid anesthetics (N01AH)
- (N01AH06)
- remifentanil (N01AH06)
MeSH Classification
- analgesics, opioid (M0001068)
Mechanism of action []
Remifentanil is a µ-opioid agonist with rapid onset and peak effect, and short duration of action. The µ-opioid activity of remifentanil is antagonized by opioid antagonists such as naloxone. [1]
Interactions []
Medical side effects []
134 side effects listed on drug labels in SIDER 4.1 (remifentanil).
- Nausea
- Pain
- Ache
- Vomiting
- Confusional state
- Feeling abnormal
- Procedural hypertension
- Post procedural complication
- Postoperative complications NOS
- Pleural effusion
- Hyperhidrosis
- Hypotension
- Hypotensive
- Constipation
- Anxiety
- Atrial fibrillation
- Chills
- Shivering
- Diarrhoea
- Post procedural infection
- Hypertension
- Pruritus
- Bradycardia
- Respiratory depression
- Pulmonary function test decreased
- Oedema
- Dizziness
- Syncope
- Pneumonia
- Muscle rigidity
- Hallucination
- Dyspepsia
- Pharyngitis
- Myocardial ischaemia
- Apnoea
- Cerebral infarction
- Headache
- Agitation
- Atelectasis
- Pneumothorax
- Hyperkalaemia
- Paraesthesia
- Convulsion
- Urinary retention
- Respiratory distress
- Tachycardia
- Flushing
- Body temperature increased
- Atrial flutter
- Dyspnoea
- Haematuria
- Sleep disorder
- Cerebral ischaemia
- Hypoxia
- Bronchospasm
- Pulmonary oedema
- Ventricular extrasystoles
- Renal failure
- Renal impairment
- Anaemia
- Haemorrhage
- Haemoglobin
- Ventricular fibrillation
- Cardiac output decreased
- Procedural pain
- Anaphylactic shock
- Cardiac arrest
- Hypersensitivity
- Amnesia
- Arrhythmia
- Coagulopathy
- Bronchitis
- Cough
- Dysphagia
- Dysuria
- Dermatitis
- Rash
- Gastrooesophageal reflux disease
- Gastrointestinal disorder
- Atrioventricular block
- Cardiac disorder
- Haemoptysis
- Hiccups
- Hyperglycaemia
- Hypokalaemia
- Body temperature decreased
- Hypothermia
- Immune system disorder
- Laryngospasm
- Leukocytosis
- Lymphopenia
- Mediastinal disorder
- Nasal congestion
- Nervous system disorder
- Nightmare
- Nystagmus
- Oliguria
- Pericarditis
- Rales
- Rhonchi
- Shock
- Stridor
- Loss of consciousness
- Thrombocytopenia
- Tremor
- Erythema
- Urinary incontinence
- Urticaria
- Angiopathy
- Dry mouth
- Ventricular arrhythmia
- Atrioventricular block first degree
- Hepatic function abnormal
- Atrioventricular block complete
- Blood creatine phosphokinase increased
- Skin disorder
- Musculoskeletal stiffness
- Muscle twitching
- Abdominal discomfort
- Disorientation
- Dysphoria
- Pulmonary congestion
- Respiratory tract congestion
- Dyskinesia
- Musculoskeletal chest pain
- Visual impairment
- Electrocardiogram change
- Infusion site reaction
- Ileus
- Nasopharyngitis
- Rhinorrhoea
- Haematochezia
- Electrolyte imbalance
- Somnolence
Subjective effects []
Legal status []
- Australia: Remifentanil is a Schedule 8.
- Brazil: Remifentanil is a A1.[3]
- Canada: Remifentanil is a Schedule I.
- Germany: Remifentanil is a Anlage III under the "Betäubungsmittelgesetz (BtMG)".
- United Kingdom: Remifentanil is a Class A under the "Misuse of Drugs Act 1971".
- United States: Remifentanil is a Schedule II under the "Controlled Substances Act".
- Other: Remifentanil is a SE: Förteckning II.[4]
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 60815, Remifentanil. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/60815
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Remifentanil. UNII: P10582JYYK. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/P10582JYYK
RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Remifentanil hameln, Pulver till koncentrat till injektions-/infusionsvätska, lösning 1 mg. FASS. 16 March 2026. https://fass.se/health/product/20210705000012/fass-text
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 16:59:33 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 16:59:29 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 16:59:29 |
| gsrs | ok | 2026-11-20 16:59:30 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0015036) | 2026-11-20 16:59:29 |
| kegg | ok | 2026-11-20 16:59:32 |
| pubchem | ok | 2026-11-20 16:59:28 |
| missing (no r/tripreports posts mention it) | 2026-11-20 16:59:28 | |
| sider | ok | 2026-11-20 16:59:29 |
| structure | ok | 2026-11-20 16:59:28 |
| wikipedia | ok | 2026-11-20 16:59:29 |